230 related articles for article (PubMed ID: 10702808)
41. [Gene diagnosis of hemolytic anemia].
Miyazaki S
Nihon Rinsho; 1996 Sep; 54(9):2416-22. PubMed ID: 8890572
[TBL] [Abstract][Full Text] [Related]
42. [Alteration of erythrocyte membrane proteins in a family with hereditary spherocytosis].
Inoue F; Matsuyama R; Yoneyama S
Nihon Ketsueki Gakkai Zasshi; 1989 Nov; 52(7):1122-7. PubMed ID: 2618557
[TBL] [Abstract][Full Text] [Related]
43. Molecular and haematological studies of four families with hereditary spherocytosis resulting from band 3 deficiency.
Maciag M; Plochocka D; Mendek-Czajkowska E; Adamowicz-Salach A; Spychalska J; Zdebska E; Jablonska-Skwiecinska E; Koscielak J; Burzynska B
Acta Haematol; 2006; 116(2):143-5. PubMed ID: 16914912
[No Abstract] [Full Text] [Related]
44. A family case of pyruvate kinase variant, PK 'Nichinan'.
Uno H; Sawano F; Fujii H; Miwa S; Tsuda K
Jpn J Med; 1990; 29(2):168-73. PubMed ID: 2232365
[TBL] [Abstract][Full Text] [Related]
45. Hereditary spherocytosis due to band 3 deficiency: 15 novel mutations in SLC4A1.
Van Zwieten R; François JJ; Van Leeuwen K; Van Wesel AC; Van Bruggen R; Van Solinge WW; Roos D; Verhoeven AJ; Van Wijk R
Am J Hematol; 2013 Feb; 88(2):159-60. PubMed ID: 23255290
[No Abstract] [Full Text] [Related]
46. Band 3 Chur: a variant associated with band 3-deficient hereditary spherocytosis and substitution in a highly conserved position of transmembrane segment 11.
Maillet P; Vallier A; Reinhart WH; Wyss EJ; Ott P; Texier P; Baklouti F; Tanner MJ; Delaunay J; Alloisio N
Br J Haematol; 1995 Dec; 91(4):804-10. PubMed ID: 8547122
[TBL] [Abstract][Full Text] [Related]
47. Genetic disorders of the red cell membranes.
Delaunay J
FEBS Lett; 1995 Aug; 369(1):34-7. PubMed ID: 7641880
[TBL] [Abstract][Full Text] [Related]
48. Biochemical and molecular characterization of variant pyruvate kinase enzymes and genes from three patients with red blood cell pyruvate kinase deficiency.
Johnson ML; Jones DP; Freeman JM; Wang W
Acta Haematol; 1991; 86(2):79-85. PubMed ID: 1683086
[TBL] [Abstract][Full Text] [Related]
49. Elevated ATP level, high activity of PK and hereditary spherocytosis--triple erythrocytic anomaly.
Swarup-Mitra S; Ghosh SK
Indian J Med Res; 1978 Feb; 67():263-8. PubMed ID: 680884
[No Abstract] [Full Text] [Related]
50. Absence of CD47 in protein 4.2-deficient hereditary spherocytosis in man: an interaction between the Rh complex and the band 3 complex.
Bruce LJ; Ghosh S; King MJ; Layton DM; Mawby WJ; Stewart GW; Oldenborg PA; Delaunay J; Tanner MJ
Blood; 2002 Sep; 100(5):1878-85. PubMed ID: 12176912
[TBL] [Abstract][Full Text] [Related]
51. Ten cases of pyruvate kinase (PK) deficiency found in Japan: enzymatic characterization of the patients' PK.
Morisaki T; Tani K; Takahashi K; Tsutsumi H; Horiuchi N; Ogura H; Kanno H; Fujimura K; Nakayama S; Watanabe C
Nihon Ketsueki Gakkai Zasshi; 1988 Sep; 51(6):1080-5. PubMed ID: 3201900
[No Abstract] [Full Text] [Related]
52. Novel type of red blood cell pyruvate kinase hyperactivity predicts a remote regulatory locus involved in PKLR gene expression.
van Oirschot BA; Francois JJ; van Solinge WW; van Wesel AC; Rijksen G; van Amstel HK; van Wijk R
Am J Hematol; 2014 Apr; 89(4):380-4. PubMed ID: 24375447
[TBL] [Abstract][Full Text] [Related]
53. Protein 4.2: a complex linker.
Satchwell TJ; Shoemark DK; Sessions RB; Toye AM
Blood Cells Mol Dis; 2009; 42(3):201-10. PubMed ID: 19269200
[TBL] [Abstract][Full Text] [Related]
54. [Analysis of a pyruvate kinase deficiency consanguineous pedigree caused by Ile314Thr homozygous mutation].
Qu Y; He H; Du J; Hou J; Fu W
Zhonghua Xue Ye Xue Za Zhi; 2014 Jul; 35(7):601-4. PubMed ID: 25052601
[TBL] [Abstract][Full Text] [Related]
55. Red cell pyruvate kinase deficiency in Southern Sardinia.
Perseu L; Giagu N; Satta S; Sollaino MC; Congiu R; Galanello R
Blood Cells Mol Dis; 2010 Dec; 45(4):280-3. PubMed ID: 20870434
[TBL] [Abstract][Full Text] [Related]
56. Transgenic rescue of hemolytic anemia due to red blood cell pyruvate kinase deficiency.
Kanno H; Utsugisawa T; Aizawa S; Koizumi T; Aisaki K; Hamada T; Ogura H; Fujii H
Haematologica; 2007 Jun; 92(6):731-7. PubMed ID: 17550844
[TBL] [Abstract][Full Text] [Related]
57. Molecular abnormality of erythrocyte pyruvate kinase deficiency in the Amish.
Kanno H; Ballas SK; Miwa S; Fujii H; Bowman HS
Blood; 1994 Apr; 83(8):2311-6. PubMed ID: 8161798
[TBL] [Abstract][Full Text] [Related]
58. Identification of red blood cell membrane defects in a patient with hereditary spherocytosis using next‑generation sequencing technology and matrix‑assisted laser desorption/ionization time‑of‑flight mass spectrometry.
Şener LT; Aktan M; Albeniz G; Şener A; Üstek D; Albeniz I
Mol Med Rep; 2019 May; 19(5):3912-3922. PubMed ID: 30896804
[TBL] [Abstract][Full Text] [Related]
59. Mutations in the R-type pyruvate kinase gene and altered enzyme kinetic properties in patients with hemolytic anemia due to pyruvate kinase deficiency.
Lakomek M; Huppke P; Neubauer B; Pekrun A; Winkler H; Schröter W
Ann Hematol; 1994 Nov; 69(5):253-60. PubMed ID: 7948315
[TBL] [Abstract][Full Text] [Related]
60. Screening of hereditary spherocytosis and pyruvate kinase deficiency by automated blood count using erythrocytic and reticulocytic parameters.
Bobée V; Daliphard S; Schrapp A; Lahary A
Int J Lab Hematol; 2018 Dec; 40(6):697-703. PubMed ID: 30184319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
